A Single-Center, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Dose of SCO-792 in the Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2018
At a glance
- Drugs SCO-792 (Primary)
- Indications Diabetes mellitus; Diabetic nephropathies; Obesity
- Focus Adverse reactions
- Sponsors SCOHIA PHARMA
- 01 Aug 2018 Status changed from recruiting to completed.
- 18 Jan 2018 New trial record